Ozempic is an FDA-approved medication for people who have type 2 diabetes. It’s often prescribed “off-label” for weight loss ...

NVO submits higher-dose Wegovy to EMA, aiming for greater weight loss and stronger defense against rivals in the obesity ...

Danish drugmaker Novo Nordisk is working to bring its blockbuster drug Ozempic to India “as soon as possible", Dr Yan Cai, ...

CHMP recommends a label update for Novo Nordisk's Ozempic after the STRIDE study shows walking improvements in T2D patients with PAD.

Trend alert! Split dosing, stretch dosing, skip dosing, microdosing Ozempic… People are finding creative ways to use ...

A NEW weight loss jab that only needs to be taken once monthly leads to “substantial weight loss”, according to early trials.

Wegovy, a weight loss drug which reduces cardiovascular risks in obese individuals, launched in India on June 24. Experts ...

There’s no such thing as "natural Ozempic." While supplements like psyllium, berberine, and glucomannan are paraded as ...

Considering GLP-1 agonists tend to perform better at higher doses, it remains to be seen if Mounjaro 15 mg would outperform Ozempic 2 mg in a head-to-head trial.

Novo Nordisk decodes India’s obesity drug market with Wegovy positioned as once-a-week novel weight management medication: Our Bureau, Bengaluru Tuesday, June 24, 2025, 15:45 Hr ...